Damaged nerves in the spinal cord do not regenerate themselves naturally, nor even under the spur of nerve-growth stimulants.
It is because of the presence of nerve-growth inhibitors in the spinal cord.
Antibodies that deactivate those inhibitors have now been developed.
Conclusion: Clearly, then, nerve repair will be a standard medical procedure in the foreseeable future.
Spinal cord has some growth inhibitors. They prevent regrowth of nerves. Antibodies that deactivate these inhibitors have been developed. We are concluding that nerve repair will become a standard procedure now.
We need to cast doubt that it will become a standard procedure now.
What if the antibodies that deactivate the inhibitors harm us in other worse ways? What if the growth inhibitors play some other crucial role in our bodies and deactivating them is harmful to us?
Then, nerve repair may not become standard procedure.
The only relevant options are (A) and (B).
(A) Prevention of the regeneration of damaged nerves is merely a by-product of the main function in the human body of the substances inhibiting nerve growth.
Correct. Inhibitors have a main function (they play some other role in our body). Inhibition of regeneration is just a by-product. If we deactivate these inhibitors, their main function will stop. It may impact our body in a much worse way. Hence, it casts doubt on the conclusion that it will become standard procedure.
(B) Certain nerve-growth stimulants have similar chemical structures to those of the antibodies against nerve-growth inhibitors.
Similar chemical structure does not mean "same". A small difference could be all that is needed to make antibodies work. So the fact that stimulants do not work does not imply that antibodies will not work either. Besides we are given that antibodies do deactivate those inhibitors. So we know that the antibodies work.
Answer (A)